Cargando…
Chirality in drug design and synthesis /
Chirality in Drug Design and Synthesis.
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Academic,
�1990.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a22000007a 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_ocn645898291 | ||
| 003 | OCoLC | ||
| 005 | 20231117033208.0 | ||
| 006 | m o d | ||
| 007 | cr bn||||||abp | ||
| 007 | cr bn||||||ada | ||
| 008 | 100702s1990 enkf ob 101 0 eng d | ||
| 040 | |a OCLCE |b eng |e pn |c OCLCE |d OCLCQ |d UIU |d OCLCF |d YDXCP |d IDEBK |d E7B |d OCLCQ |d UKAHL |d VLY |d LUN |d UKQUB |d OCLCQ |d OCLCO |d COM |d OCLCO |d OCL |d OCLCQ |d OCLCO | ||
| 019 | |a 608614011 |a 872652718 |a 1100878818 |a 1162414632 |a 1179424493 |a 1233319273 | ||
| 020 | |a 130648071X |q (ebk) | ||
| 020 | |a 9781306480710 |q (ebk) | ||
| 020 | |a 9781483288246 |q (e-book) | ||
| 020 | |a 1483288242 | ||
| 020 | |z 0121366707 | ||
| 020 | |z 9780121366704 | ||
| 035 | |a (OCoLC)645898291 |z (OCoLC)608614011 |z (OCoLC)872652718 |z (OCoLC)1100878818 |z (OCoLC)1162414632 |z (OCoLC)1179424493 |z (OCoLC)1233319273 | ||
| 042 | |a dlr | ||
| 050 | 4 | |a QP517.C57 |b C45 1990 | |
| 082 | 0 | 4 | |a 615.3 |2 20 |
| 084 | |a 44.42 |2 bcl | ||
| 245 | 0 | 0 | |a Chirality in drug design and synthesis / |c edited by C. Brown. |
| 260 | |b Academic, |c �1990. | ||
| 300 | |a 1 online resource (xv, 243 pages, 4 unnumbered pages of plates) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | |3 Use copy |f Restrictions unspecified |2 star |5 MiAaHDL | ||
| 533 | |a Electronic reproduction. |b [Place of publication not identified] : |c HathiTrust Digital Library, |d 2010. |5 MiAaHDL | ||
| 538 | |a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002. |u http://purl.oclc.org/DLF/benchrepro0212 |5 MiAaHDL | ||
| 583 | 1 | |a digitized |c 2010 |h HathiTrust Digital Library |l committed to preserve |2 pda |5 MiAaHDL | |
| 588 | 0 | |a Print version record. | |
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | |a Front Cover; Dedication; Chirality in Drug Design and Synthesis; Copyright Page; Contributors; Foreword; Table of Contents; Introduction; Chapter 1. Chirality: Pharmacological Action and Drug Development; Introduction; 2 Terminology; 3 Enantioselectivity in pharmacological activity; 4 Enantioselectivity in pharmacodynamics resulting from differences in the pharmacokinetics of the enantiomers; 5 Conclusion; References; Chapter 2. Racemic Therapeutics-Problems all Along the Line; 1 Introduction; 2 Implications of chirality in bioactive agents; 3 Clinical pharmacology of racemic therapeutics | |
| 505 | 8 | |a 4 Ethical aspects of drug development, evaluation and use5 Non-information and disinformation in the field of chirality; 6 Racemates as drug combinations; 7 Perspectives; 8 Summary; References; Chapter 3. Chirality, Drug Metabolism and Action; 1 Introduction; 2 Stereochemistry and drug disposition; 3 Stereoselective metabolism and drug action; 4 Conclusions; References; Chapter 4. From Enzyme Mimics to Molecular Self-Assembly Processes; 1 Introduction; 2 A gift from nature; 3 Needs of enzyme mimics; 4 Serendipity yet again; 5 A chiral crown ether as a reagent | |
| 505 | 8 | |a 6 The same chiral crown ether as a catalyst7 Coordination through the second sphere; 8 Planned molecular self-assembly; 9 From host-guest chemistry to molecular assemblies; 10 Structure-directed synthesis; 11 The future; Acknowledgements; References; Chapter 5. Modelling of Drug-Receptor Interactions: Stereoselectivity of 5-Hydroxytryptamine and Dopamine Receptors in the Brain; 1 Introduction; 2 Interactions between L-ZGP and 8-OH DPAT; 3 Modelling of drug-receptor interactions; 4 DA D2-receptor agonists and antagonists; 5 5-HT1A-receptor agonists and antagonists; Acknowledgements; References | |
| 505 | 8 | |a Chapter 6. Molecular Basis of the Activity of Antibiotics of the Vancomycin Group:Guides for Peptide-Peptide Binding1 Introduction; 2 Stereoselectivity; 3 Peptide-peptide molecular recognition; 4 Approximate binding constants estimated for simple carboxylic acids; 5 A molecular interpretation of the binding process; Acknowledgements; References; Chapter 7. Recent Developments in the Use of Enzyme-Catalysed Reactions in Organic Synthesis; 1 Introduction; 2 Recent uses of hydrolase enzymes; 3 Recent uses of oxidoreductase enzymes | |
| 520 | |a Chirality in Drug Design and Synthesis. | ||
| 546 | |a English. | ||
| 650 | 0 | |a Pharmaceutical chemistry. | |
| 650 | 0 | |a Drugs. | |
| 650 | 0 | |a Organic compounds |x Synthesis. | |
| 650 | 2 | |a Chemistry, Pharmaceutical |0 (DNLM)D002626 | |
| 650 | 2 | |a Pharmaceutical Preparations |0 (DNLM)D004364 | |
| 650 | 6 | |a M�edicaments. |0 (CaQQLa)201-0002990 | |
| 650 | 6 | |a Compos�es organiques |x Synth�ese. |0 (CaQQLa)201-0020323 | |
| 650 | 6 | |a Chimie pharmaceutique. |0 (CaQQLa)201-0028674 | |
| 650 | 7 | |a Drugs |2 fast |0 (OCoLC)fst00898761 | |
| 650 | 7 | |a Organic compounds |x Synthesis |2 fast |0 (OCoLC)fst01047668 | |
| 650 | 7 | |a Pharmaceutical chemistry |2 fast |0 (OCoLC)fst01060115 | |
| 653 | |a Drugs |a Synthesis | ||
| 655 | 2 | |a Congress |0 (DNLM)D016423 | |
| 655 | 7 | |a proceedings (reports) |2 aat |0 (CStmoGRI)aatgf300027316 | |
| 655 | 7 | |a Conference papers and proceedings |2 fast |0 (OCoLC)fst01423772 | |
| 655 | 7 | |a Conference papers and proceedings. |2 lcgft | |
| 655 | 7 | |a Actes de congr�es. |2 rvmgf |0 (CaQQLa)RVMGF-000001049 | |
| 700 | 1 | |a Brown, C. | |
| 776 | 0 | 8 | |i Print version: |t Chirality in drug design and synthesis. |d Academic, �1990 |w (OCoLC)22624397 |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780121366704 |z Texto completo |